Vaxcyte, Inc.
PCVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,986,674 | $6,101,460 | $3,110,900 | $1,235,224 |
| - Cash | $387,878 | $397,451 | $834,657 | $68,985 |
| + Debt | $71,110 | $29,224 | $17,941 | $16,783 |
| Enterprise Value | $9,669,906 | $5,733,233 | $2,294,184 | $1,183,022 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$448,082 | -$392,095 | -$214,030 | -$96,613 |
| % Margin | – | – | – | – |
| Net Income | -$463,927 | -$402,266 | -$223,485 | -$100,077 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.8 | -4.14 | -3.44 | -1.93 |
| % Growth | 8.2% | -20.3% | -78.2% | – |
| Operating Cash Flow | -$452,627 | -$296,790 | -$170,597 | -$121,393 |
| Capital Expenditures | -$22,427 | -$67,877 | -$5,841 | -$6,555 |
| Free Cash Flow | -$475,054 | -$364,667 | -$176,438 | -$127,948 |